Influenza A+B Rapid Test – Product code: SC-0623-20
Rapid test for the qualitative detection of the Influenza A and Influenza B virus on samples of nasal swab, throat swab or nasal aspirate. The Influenza A + B rapid test is a rapid immunochromatographic test for the qualitative identification of influenza A and B antigens on nasal, pharyngeal or nasal aspirate swab samples. It is intended to assist in the rapid differential diagnosis of viral infections of influenza A and B. Influenza is an acute, highly contagious viral infection of the respiratory tract. It is a highly transmissible contagious disease through coughing and sneezing from suspended droplets containing the live virus. The peak of the flu usually occurs during the winter and autumn months each year. Type A viruses are usually more prevalent than type B and associated with more serious influenza outbreaks, while type B infections are usually milder. The gold standard for laboratory diagnosis is culture at 14 days with one of a variety of cell lines that can support the growth of the influenza virus. Cell cultures have limited clinical utility, since the results are obtained too late in the clinical course for an effective intervention on the patient. The Reverse Transcriptase Polymerase Chain Reaction (RT_PCR) is a newer and generally more sensitive culture method with better detection rates than a 2-23% culture. However, RT-PCR is expensive, complex and must be performed in specialized laboratories. The rapid test for Influenza A + B (Swab/Nasal Aspirate) qualitatively identifies the presence of influenza A and / or B antigen on nasal swab, pharyngeal or nasal aspirate samples, providing results in 15 minutes. The test uses specific antibodies for Influenza A and Influenza B to selectively identify the antigen of Influenza A and / or B on samples of nasal swab, pharyngeal or nasal aspirate. The rapid test for Influenza A + B (Swab/Nasal Aspirate) is a qualitative lateral scrolling immunoassay for the identification of influenza A and B nucleopreoteins on nasal, pharyngeal or nasal aspirate swab samples. In this test, an antibody specific to the nucleoproteins of Influenza A and Influenza B separately covers the areas of the test line on the support. During the test, the extracted sample reacts with the antibody to Influenza A and / or B which covers the particles. The compound migrates upwards on the membrane to react with the antibody to Influenza A and / or B on the membrane and generate one or two colored lines in the test areas. The presence of this colored line on one or both test areas indicates a positive result. As a procedural control, a line always appears in the test control zone if it has been performed correctly.